Back
Science

Study Links Pediatric Sleep Apnea to Increased Risk of Viral Infections

Generated on: Last updated: 2 sources
View source

Sleep Apnea in Children Linked to Heightened Risk of Viral Respiratory Infections

A five-year study has identified a link between sleep apnea in children and a heightened risk of contracting viral respiratory infections, including influenza and COVID-19. The research indicated that children diagnosed with sleep apnea were up to 2.5 times more likely to contract these illnesses and faced an increased risk of complications such as pneumonia, regardless of age or weight.

Research Overview

The study, published in the Journal of Clinical Sleep Medicine, tracked over one million children aged 2 to 18 using the TriNetX global health database for five years. The research was led by Dr. Alex Gileles-Hillel and Dr. Joel Reiter from the Faculty of Medicine at the Hebrew University, along with Dr. David Gozal from Marshall University.

Dr. Moira Junge, CEO of the Sleep Health Foundation, noted that sleep apnea diagnoses are common among children and are often an underlying factor in cases where tonsils and adenoids are removed.

Key Findings

The study's findings included:

  • Children with sleep apnea had an 80% higher risk of contracting influenza compared to those without the condition.
  • The risk for COVID-19 was approximately 2.5 times higher for children diagnosed with obstructive sleep apnea (OSA).
  • A higher risk of developing pneumonia as a complication of these viral infections was also observed in children with sleep apnea.

This increased vulnerability was noted to persist even after surgical removal of tonsils or adenoids.

Potential Mechanisms and Implications

Researchers suggested that this vulnerability stems from immune dysregulation. Dr. Alex Gileles-Hillel noted that dysregulation of immune milieus in pediatric OSA might explain both the increased susceptibility to viral infection and the potential for more severe symptoms.

The study found that adenotonsillectomy (surgical removal of tonsils and adenoids) did not significantly reduce the risk of infection. Dr. David Gozal suggested this could be attributed to some children experiencing residual sleep apnea post-procedure or to OSA-related immune dysregulation impairing an appropriate immune response.

The findings propose that a sleep apnea diagnosis should be considered a "risk marker." This designation could indicate a need for consistent seasonal vaccinations to help prevent severe respiratory complications.

Dr. Joel Reiter stated that viewing sleep apnea as a practical flag for preventive health could support prioritizing these children for annual vaccinations. Dr. Alex Gileles-Hillel added that framing OSA as a "risk marker" may assist in routine pediatric counseling for vaccination.